Columbus A/S
1.9.2025 10:13:42 CEST | Globenewswire | Press release
Columbus – Weekly report on share buyback
Columbus – Weekly report on share buyback
Company announcement no. 19/2025
Transactions in the period 25 August 2025 to 29 August 2025
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company announcement no. 8/2025.
The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buyback programme in the period 25 August 2025 to 29 August 2025:
| Number of shares bought | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, last announcement | 511,749 | 10.10 | 5,170,826.75 |
| 25 August 2025 | 12,000 | 10.01 | 120,072.00 |
| 26 August 2025 | 10,000 | 9.88 | 98,800.00 |
| 27 August 2025 | 10,000 | 9.80 | 98,000.00 |
| 28 August 2025 | 11,000 | 9.82 | 108,020.00 |
| 29 August 2025 | 11,000 | 9.80 | 107,800.00 |
| Total, 25 August 2025 to 29 August 2025 | 54,000 | 9.86 | 532,692.00 |
| Total accumulated under the programme | 565,749 | 10.08 | 5,703,518.75 |
With the transactions stated above, Columbus A/S holds a total of 565,749 own shares, corresponding to 0.44% of the Company’s share capital.
Ib Kunøe Søren Krogh Knudsen
Chairman of the Board CEO & President
For further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00 |
Attachments
- SE_19_2025_Weekly_report_on_share_buyback
- Columbus - Share buyback transactions 25 August 2025 - 29 August 2025
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom